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ABSTRACT
The use of genome-wide and high-throughput
screening methods on large sample sizes is a
well-grounded approach when studying a process
as complex and heterogeneous as tumorigenesis.
Gene copy number changes are one of the main
mechanisms causing cancerous alterations in
gene expression and can be detected using array
comparative genomic hybridization (aCGH).
Microarrays are well suited for the integrative
systems biology approach, but none of the existing
microarray databases is focusing on copy number
changes. We present here CanGEM (Cancer
GEnome Mine), which is a public, web-based data-
base for storing quantitative microarray data and
relevant metadata about the measurements and
samples. CanGEM supports the MIAME standard
and in addition, stores clinical information using
standardized controlled vocabularies whenever
possible. Microarray probes are re-annotated with
their physical coordinates in the human genome and
aCGH data is analyzed to yield gene-specific copy
numbers. Users can build custom datasets by
querying for specific clinical sample characteristics
or copy number changes of individual genes.
Aberration frequencies can be calculated for these
datasets, and the data can be visualized on the
human genome map with gene annotations.
Furthermore, the original data files are available for
more detailed analysis. The CanGEM database can
be accessed at http://www.cangem.org/.
INTRODUCTION
With the exception of few hematologic malignancies
that are characterized by a single chromosomal change,
e.g. the BCR-ABL1 fusion gene in chronic myelogenous
leukemia (1), cancer is generally a complex disease.
Especially carcinomas, which usually undergo prolonged
carcinogenesis and account for over 80% of cancer-related
deaths (2), are usually characterized by chaotic genomic
changes. Chromosomal or gene copy number alterations
are one of the most important mechanisms that perturb
normal gene function by inducing changes reﬂected in
gene expression (3). Other types of changes include
mutations (inherited or somatic), translocations and
changes in epigenetic make-up that aﬀect the gene
regulation machinery and protein structure and function.
During carcinogenesis and cancer progression, activation
and malfunction of a number of cancer genes are
required for cancer cells to gain the independence of
growth supporting signaling and immunity to growth
restrains, evade apoptosis and replicate unlimitedly,
sustain angiogenesis and escape the control of the
anatomical primary site, thus, acquire the hallmarks of
cancer (4). In addition to cancer, gene copy number
aberrations are also important in many congenital
disorders, especially small deletions that are detectable
using high-resolution aCGH.
Array comparative genomic hybridization (aCGH) is
a technique that uses microarrays to detect changes in
gene copy number, and is widely used in cancer research
to characterize diﬀerent tumors and hematologic malig-
nancies (5). Arrays can be manufactured using diﬀerent
techniques, and recently synthetic oligonucleotides have
been gaining popularity from spotted BAC or cDNA
clones (6). As the selection of used arrays is wide, it is
necessary to be able to integrate data measured with
diﬀerent platforms, in order to be able to do large-scale
studies. This is further emphasized by the in-house
manufactured spotted arrays.
Copy number aberrations comprise of deletions and
ampliﬁcations, which promote cancer by acting on tumor
suppressor genes and proto-oncogenes, respectively. These
genes can be commonly termed as ‘cancer genes’. Because
aberrations are formed through a process of common
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followed by natural selection, the altered genomic
regions usually contain not only cancer genes, but also
bystanders. Identiﬁcation of the driving genes is essential
in understanding cancer biology as well as for clinical
applications, namely, prognostics, diagnostics and thera-
peutics, where speciﬁc targets are sought after. Because
of the complexity of carcinogenesis and the nature of
the process creating aberrations, large-scale screening
studies are needed to achieve this goal.
The existing microarray databases [such as
ArrayExpress (7), Gene Expression Omnibus (8), and
Stanford MicroArray Database (9)] are focused on gene
expression data and do not provide tools for studying
copy number changes. We present here CanGEM (Cancer
GEnome Mine), which is a public, web-based database
service for storing clinical information about tumor
samples and related microarray data. Emphasis is on
copy number changes, but also other types of microarray
data can be stored, including locus heterogeneity and
gene expression data, typically when collected from the
same samples.
DESIGN, IMPLEMENTATION AND USAGE OF
CANGEM
Database structure
The structure of the CanGEM database is MIAME-
compliant (10) and ﬂexible in allowing the storage of
diﬀerent ﬁle formats from diﬀerent software packages.
Figure 1 summarizes the relationships between diﬀerent
data entities that are used in this article to describe
the database.
Annotation of samples
In order to support systematic research, samples in
CanGEM are annotated using classiﬁcation systems
based on controlled vocabularies, instead of free text
descriptions common in many gene expression microarray
databases. To describe the topographical and morpholo-
gical attributes of the cancer, we are using chapter II
(Neoplasms) of the International Statistical Classiﬁcation
of Diseases and Related Health Problems (10th Revision;
ICD-10) and International Classiﬁcation of Disease for
Oncology (3rd Edition; ICD-O-3) of the World Health
Organization (WHO). They are both three-step hierarchi-
cal ontologies that allow a precise classiﬁcation of the
cancer types and morphologies. If it is not possible to
classify a particular sample up to the most detailed level,
the deﬁnition can be left at the previous, broader stage.
It is also possible to assign multiple deﬁnitions to a
single sample.
We have also adopted the classiﬁcation system of
the eVOC Ontology, which is a set of ontologies developed
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Figure 1. Database structure. This ﬁgure summarizes the relationships
between the diﬀerent data entities that are used in the database.
Microarray results are obtained from a single microarray hybridization
and contain a text ﬁle with a numerical representation of the measured
spot intensities obtained from the scanned array with an image analysis
software. It can also include the image ﬁle itself. In addition to these
ﬁles, results contain links to the biological specimens (samples),
experimental procedures (protocols) and the speciﬁc microarray plat-
form that were used to obtain the results. The protocols section is
divided into eight diﬀerent stages: extraction, digestion, ampliﬁcation,
labeling, hybridization, washing, scanning and image analysis. Together
they correspond to the methods section of an article preceding the
data analysis stage. Sample and protocol information is submitted
to the database separately from the microarray results to allow the
reuse of the same samples and protocols for multiple hybridizations.
An example is a study that integrates the results of multiple array
techniques, such as both copy number and expression data. A number
of results can be combined into a series, and multiple series can
be further combined to form an experiment, which corresponds to
a published article. All of the data entities mentioned above are
contained within projects, which allow user permissions to be speciﬁed
on a per user account or per research group basis. The service can
therefore be used to aid data sharing between collaborators in
preliminary prepublication stages, or to give access to manuscript
referees. Even though this could also allow the users to continue to
limit the availability of their data, everything uploaded to the CanGEM
database should be made publicly available once the researchers’ get
their results published. There are also two data types that are user-
account speciﬁc: uploads and datasets. They are only visible to that
speciﬁc user account. Uploads are ﬁles (e.g. microarray result ﬁles) that
have been uploaded to the web server, but not yet used to create an
actual database entry. Datasets are user-deﬁned collections of micro-
array data, and can be constructed manually or as saved search queries.
These smart datasets get updated automatically and can be conﬁgured
to send email alerts when their contents change, i.e. when new
microarray data become available that match previously deﬁned search
criteria, e.g. of tissue type, cancer type and age group of interest. The
diﬀerence between datasets and microarray results, series and experi-
ments, is that the latter ones are deﬁned by the original submitter and
are the same for everybody, while every user can create custom datasets
to meet their speciﬁc needs.
, Asterisk represent the numbers next to
the lines connecting the boxes describe the relationship between the two
data entities. For example, each microarray result is linked to either
one or two samples depending on the array type, and this is denoted
with 1..2. Each sample can be used for an arbitrary number of
microarray results, which is depicted with the symbol.
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of 10 categories, of which we are using six: anatomical
system, cell type, development stage, pathology, tissue
preparation and treatment. eVOC provides hierarchical
classiﬁcation systems with a varying number of levels.
As with ICD, it is possible to assign multiple ontology
terms to a single sample.
For classifying the stage of the cancer, we are using the
TNM Classiﬁcation, which is a systematic way of
describing the size and spread of a tumor. It uses three
values to describe the size of the primary tumor (T), and
whether the cancer has spread to the lymph nodes (N), or
to more distant locations in the body (M).
In addition to these classiﬁcation systems, we are also
collecting information about exposure to environmental
risk factors, patient sex, tumor size, survival, cause of
death, and whether surgery has been done and if it was
curative or not. All of the clinical attributes as well as the
ICD and eVOC ontologies can be used to search for
samples in the database.
Our current sample annotations are rather cancer-
speciﬁc, but in the future we will be updating the system
to better account for other possible uses of array CGH.
Annotation of microarrayplatforms
Diﬀerent microarray platforms contain diﬀerent sets of
probes identiﬁed by diﬀerent sets of IDs, which makes
it diﬃcult to integrate data from multiple sources.
When working with array CGH, this problem is further
complicated by the fact that the technique is not gene-
centric. BAC arrays, still used for CGH, contain probes
that can be 300kb long and contain several genes. Oligo
arrays on the other hand can contain probes that have
been speciﬁcally designed to match regions between genes.
To overcome this problem, we are using probe sequences
to re-annotate the microarray probes to physical coordi-
nates of the human genome with a custom iterative
algorithm based on MegaBlast (12). Further, this
approach enables CanGEM to unite aCGH, LOH and
gene expression data through physical coordinates in
the future.
In the case of oligonucleotide arrays, the entire sequence
of the probe is known, and it often corresponds to
an unambiguous and continuous chromosomal sequence.
However, with cDNA probes, in most cases, intronic
regions split probes to more than one matching exons
resulting in multiple blast hits. Also, in the case of
cDNA or BAC arrays, the probes are generally too long to
be sequenced entirely, and the sequenced sections are from
the ends of the probe (preferably from both). After all the
sequences for a speciﬁc probe have been analyzed,
CanGEM joins the mapping results together if all hits
are from the same chromosome, and the entire length
of the joined probe does not exceed 2.5 Mbp of genomic
DNA (the longest human gene in Ensembl 45 is 2 304 117
base pairs). If these conditions are not met, the probe
is marked as ambiguous and excluded from further
analysis. The probe-to-genome mapping results are
saved to CanGEM and used for analysis of submitted
microarray data, and the mapping procedure is repeated
when a new build of the human genome becomes
available. Currently, all the microarray platforms
available in CanGEM have been mapped to both NCBI
builds 35 and 36. The mapping process is illustrated in
Figure 2A.
Currently, the two-color platforms suitable for
array CGH in CanGEM include cDNA and oligo-based
arrays from Agilent Technologies (12K cDNA, 22K
oligos, 44K oligos for CGH and expression, 244K oligo
CGH) and one custom cDNA array. Supported one-color
expression platforms include Aﬀymetrix U133 and U95
arrays. Furthermore, introduction of new array platforms
is done easily.
Submission of datato CanGEM
CanGEM is an open and publicly accessible data
repository. However, in order to submit data to
CanGEM, users need to register for a (free) user account,
which then becomes the owner of that data. Currently,
all data submission operations are done through a web
browser, and the diﬀerent data entities are created by
ﬁlling out simple web forms. For submissions of larger
sets of data, a batch tool is available for inserting
multiple microarray results. Also, new samples can be
created using an existing one as a template speeding
up the process, as samples in a single microarray experi-
ment usually share similar characteristics. Step-by-step
documentation of the submission process can be found
from the CanGEM website. The availability of the
submitted data can be controlled as explained in more
detail in the legend of Figure 1.
This project has been reviewed and approved by
the Ethical Review Board of Helsinki and Uusimaa
Hospital District and authorized by the Clinical Review
Board of Helsinki University Central Hospital. For
ethical reasons, it is forbidden to store any information
that could identify the individual patients in CanGEM.
This includes any kind of identiﬁcation codes, but can
also encompass extremely rare clinical cases, whose
uniqueness could be individualizing. It is the responsibility
of the user submitting data to ensure that this require-
ment is fulﬁlled, and therefore users willing to submit data
to CanGEM have to get a free user id and password.
Processing ofthe datasubmitted toCanGEM
After a microarray experiment is uploaded to the data-
base, the data are analyzed using a predeﬁned procedure.
The process is semi-automated, involving the data being
checked by a human curator. This only includes technical
details, such as ensuring that the sample attributes are
in place, but does not cover quality control of the
arrays, which is left to the user. The details of the analysis
algorithm for the R statistical analysis environment can
be found from the library package provided on the
CanGEM website. In brief, the data are ﬁltered for
outliers, background-corrected and lowess normalized in
R/Bioconductor using the limma package (13). As the
normalization procedure is the same for all diﬀerent
microarray platforms, we have chosen not to use methods
that depend on the array design, such as print-tip lowess.
D832 Nucleic Acids Research, 2008, Vol. 36, DatabaseissueDiﬀerent normalization schemes for array CGH data have
been compared in (14) and of the included methods that
are not dependent on array design, lowess was found to
perform best in removing technical bias, while maintain-
ing the biological signiﬁcance. After normalization, the
data is combined with the physical coordinates for the
speciﬁc microarray platform precalculated with the probe-
to-genome analysis, and all the probes that have been
marked as ambiguous or did not produce any hits are
removed. Also, data from chromosome Y is removed if
the patient is not a male and chromosomes X and Y if the
sex does not match with the reference sample. The CGH
proﬁles are calculated using the ACE algorithm of the
CGH Explorer program (15), which converts the log
ratios to discrete levels of normal, ampliﬁed, or deleted
copy number, represented with the numbers 0, 1 and 1,
respectively. The algorithm also calculates estimates of
false discovery rates, and the ‘medium’ option is selected
from the presented alternatives balancing between sensi-
tivity and speciﬁcity.
Because diﬀerent array platforms contain diﬀerent
probes targeting diﬀerent areas of the genome, the results
are converted to gene-speciﬁc copy numbers as follows.
For each gene, it is ﬁrst checked if there are probes on
the array that overlap with the position of the gene, in
which case the copy number for that gene is calculated
from the overlapping probes. If there are no such probes,
the copy number is calculated from the values of the
last preceding probe and the ﬁrst one tailing the gene.
If the probes in question all have the same value (1; 0;
+1), then that value is chosen for the gene. If they have
diﬀerent values, the gene gets a copy number of 0,
meaning normal or unchanged, state. This process is
illustrated in Figure 2B. The gene-speciﬁc copy numbers
are then stored in the database to allow searching, and
calculations of aberration frequencies.
Browsing andsearching CanGEM data
Data in CanGEM can be searched either using a free-text
search box on the front page of the service, or by using
a detailed search form for complex queries using the
clinical attributes used to describe samples. This also
includes the hierarchical classiﬁcation systems of ICD and
eVOC, in which case a search for a more generic term
(e.g. digestive organs) also returns all the results that have
been mapped to a child of that ontology term
(e.g. stomach and colon). It is also possible to search
using the copy number status of a given gene. Further,
search results can be saved as datasets for future reference
and gene aberration frequencies can be calculated
and visualized for these subsets of CanGEM data.
Datasets that have been created by saving search results
another
chromosome
CGH microarray probes
blast hits
probe coordinates
blast sequences
join hits if possible
AMBIGUOUS
A
B
probe coordinates
genes
convert copy numbers from
probe to gene-based
Figure 2. (A) Mapping probes to physical coordinates of the genome. First, all available sequences for a speciﬁc probe are analyzed with MegaBlast,
and the results are joined together if they meet the conditions outlined in the main text. The ﬁgure shows this process for ﬁve probes on a CGH
microarray. Probe 1 yields two blast hits, which are joined together to get the coordinates for that probe. Probes 2, 3 and 5 only produce single hits.
Probe 4 gives two matches that are in diﬀerent chromosomes, and the probe is therefore marked as ambiguous and excluded. (B) Converting probe-
based data to gene copy numbers. The physical coordinates of the microarray probes, obtained through the predone probe-to-genome mapping
process for the used array platform, are used to convert probe-based copy number data to gene-centric. The image shows three genes in this genomic
region. The position of gene 1 overlaps with probe 1 on the array, so the copy number of gene 1 is the same as the copy number of probe 1. Gene 2
has two overlapping probes (2 and 3), so its copy number is calculated from these two probes. Gene 3 has no overlapping probes, so its value is
derived from the last preceding probe (3) and the ﬁrst one tailing the gene (probe 5). If the copy number for a gene is calculated from multiple
probes, and all these probes share the same value (1, 0 or +1), the gene will receive the same value. If the probes have diﬀerent values, the gene will
be assigned a normal, or unchanged, copy number (0).
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the search conditions becomes available, and email
alerts can be sent for such changes. Diﬀerent microarray
data entities are shown using a hierarchical browsing
interface as shown in Figure 3.
Data visualization
CanGEM provides an integrated data visualization
engine, based on GBrowse (16) and Dazzle/DAS (17)
packages. The selected samples are shown with the
CGH copy number data on the human genome, together
with other annotations from a local installation of
the Ensembl database. The user can zoom into a
particular region of interest and select the preferred sets
of annotations to be displayed. The visualization system
provides a quick and easy way to see chromosomal
aberrations in the regions of interest and an example
of the output is shown in Figure 3. For individual samples,
the user can choose to display log ratios and/or probe
or gene-based copy numbers. For a collection of samples,
the plot shows the frequencies of gains and losses.
It is also possible for users to visualize their own
private annotations together with data from CanGEM,
or to use another visualization agent that supports the
GFF ﬁle format.
Retrieval of datafrom CanGEM
All the data submitted and made publicly available can
be downloaded, together with the original raw data ﬁles
as well as the CanGEM processed numerical data.
This allows e.g. performing custom data analysis using
the software package and algorithm of choice.
Downloading can be done from the web user interface,
or using the provided library package for the R statistical
analysis environment. Documentation for the available
functions is provided within the package.
DISCUSSION
We have presented here a database service for storing
clinical information about tumor samples and microarray
data, with emphasis on array CGH. The probes on
diﬀerent microarray platforms are mapped to physical
coordinates of the human genome and microarray
data are analyzed to yield gene-speciﬁc copy numbers
facilitating the integration of data measured with diﬀerent
array platforms. Data mining of gene copy number
changes provides valuable insight into the extremely
complicated process of tumorigenesis, and public data-
bases are a prerequisite for this kind of large-scale
analysis. Such an approach is indispensable when trying
to ﬁnd aberrations that correlate with a speciﬁc diagnostic,
prognostic or therapeutic trait, such as poor prognosis
or drug resistance. These features might go unnoticed
in individual studies, because of the heterogeneity in
the processes of tumor progression and aberration
formation, but public databases help to improve the
statistical power of such analyses.
Figure 3. (A) Browsing interface. A hierarchical user interface is provided for accessing microarray data. (B) Data visualization. The GBrowse
software package showing both gene and probe-based copy number aberrations and also the original probe log ratios.
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